Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib

Anja Lachenmayer, Sara Toffanin, Laia Cabellos, Clara Alsinet, Yujin Hoshida, Augusto Villanueva, Beatriz Minguez, Hung Wen Tsai, Stephen C. Ward, Swan Thung, Scott L. Friedman, Josep M. Llovet

Research output: Contribution to journalArticlepeer-review

135 Scopus citations

Fingerprint Dive into the research topics of 'Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib'. Together they form a unique fingerprint.

Medicine & Life Sciences